The inability to handle recursion hampers AI's performance in tasks. In particular, AI can fail in programming tasks where some bit of code repeats a smaller, atomic version of the same code.

SALT LAKE CITY, Nov. 20, 2024-- The business combination of two AI-powered drug discovery and development companies, Recursion and Exscientia has been completed, with Exscientia becoming a wholly ...